Document is current
Any future updates will be listed below
-
Authors
Cao, Zhujun
Zhang, Chenxi
Zhao, Shuang
Sheng, Zike
Xiang, Xiaogang
Li, Ruokun
Qian, Zhuping
Wang, Yinling
Chen, Bin
Li, Ziqiang
Liu, Yuhan
An, Baoyan
Zhou, Huijuan
Cai, Wei
Wang, Hui
Gui, Honglian
Xin, Haiguang
Xie, Qing https://orcid.org/0000-0002-2582-8803
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82000588, 82070604, 81900567)
the “Chenguang Program” supported by Shanghai Education Development Foundation and Shanghai Municipal Education Commission
the Chinese foundation for hepatitis prevention and control-TianQing liver disease research fund subject (TQGB20210021)
Shanghai Municipal Key Clinical Specialty (shslczdzk01103)
- License Information
-
More Information
Article History
Received: 24 February 2022
Accepted: 5 May 2022
First Online: 16 May 2022
Declarations
:
: All patients’ identifers were removed from the data before extraction from the database. No personal identifers were used during analysis and presentation. This study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Ethics Review Committees at Ruijin hospital (2018-LLS-162).
: Not applicable.
: The authors declare that they have no competing interests.
